Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals 
Spirit Airlines Shuts Down Flights, Issues Refunds After Financial Collapse 
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift 
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy 
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal 
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain 
BHP Attracts AI-Focused Investors as Copper Demand Surges 
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
Agentic AI Boom to Drive Massive Growth in CPU Market, UBS Says 
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours 
TEANECK, N.J., May 07, 2018 -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on June 27, 2018, to stockholders of record at the close of business on June 6, 2018.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. For further information, please visit www.pahc.com.
Contact:
Richard Johnson
Chief Financial Officer, Phibro Animal Health Corporation
+1 201-329-7300
[email protected]
